Favrille, Inc. Selects Camstar’s MES For The Manufacture Of Personalized Medicines In The Biotech Industry; Electronic Batch Records Critical As Biopharmaceutical Company Moves Toward Commercialization Of Its Lead Product Candidate

Camstar, the leading provider of enterprise manufacturing execution and quality management solutions, announced today that Favrille, a biopharmaceutical company developing patient-specific cancer immunotherapies, has selected Camstar’s manufacturing execution system (MES), InSite, to replace the company’s current paper-driven batch records to streamline processes.